Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Respiratory Investigation|December 3, 2014
Recent evidence, advances, and current practices in surgical treatment of lung cancerKenichi Suda, Katsuaki Sato, Hiroshi Mizuuchi, et al.
Lung Cancer (Amsterdam, Netherlands)|February 19, 2017
Effect of dasatinib on EMT-mediated-mechanism of resistance against EGFR inhibitors in lung cancer cellsYuichi Sesumi, Kenichi Suda, Hiroshi Mizuuchi, et al.
Plos One|April 16, 2015
Collateral chemoresistance to anti-microtubule agents in a lung cancer cell line with acquired resistance to erlotinibHiroshi Mizuuchi, Kenichi Suda, Katsuaki Sato, et al.
Lung Cancer (Amsterdam, Netherlands)|June 19, 2014
CRKL amplification is rare as a mechanism for acquired resistance to kinase inhibitors in lung cancers with epidermal growth factor receptor mutationKenichi Suda, Hiroshi Mizuuchi, Isao Murakami, et al.
Scientific Reports|September 25, 2015
Small cell lung cancer transformation and T790M mutation: complimentary roles in acquired resistance to kinase inhibitors in lung cancerKenichi Suda, Isao Murakami, Kazuko Sakai, et al.
Radiology Case Reports|August 22, 2025
Placental transmogrification of the lung: A case report with computed tomography-pathologic correlationAyumi Kamei, Yasunari Yamada, Hiroshi Baba, et al.
Aging and Disease|December 20, 2012
Genetic and Prognostic Differences of Non-small Cell Lung Cancer between Elderly Patients and Younger CounterpartsKenichi Suda, Kenji Tomizawa, Hiroshi Mizuuchi, et al.
International Journal of Cancer|September 16, 2015
Impact of bevacizumab in combination with erlotinib on EGFR-mutated non-small cell lung cancer xenograft models with T790M mutation or MET amplificationKoh Furugaki, Junko Fukumura, Toshiki Iwai, et al.
Molecular Cancer Therapeutics|July 28, 2018
CD44 Facilitates Epithelial-to-Mesenchymal Transition Phenotypic Change at Acquisition of Resistance to EGFR Kinase Inhibitors in Lung CancerKenichi Suda, Isao Murakami, Hui Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 25, 2015
EGFR Exon 18 Mutations in Lung Cancer: Molecular Predictors of Augmented Sensitivity to Afatinib or Neratinib as Compared with First- or Third-Generation TKIsYoshihisa Kobayashi, Yosuke Togashi, Yasushi Yatabe, et al.
Pageof 4